πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to Reviva Pharmaceuticals Holdings, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

losmapimod and FTX-6058

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.

Tags: FTX-6058, biopharmaceutical, clinical-stage, facioscapulohumeral muscular dystrophy, genetically defined diseases, hemoglobinopathies, losmapimod, sickle cell disease

Symbol: FULC

Recent Price: $4.68

Industry: Biotechnology

CEO: Mr. Alexander C. Sapir

Sector: Healthcare

Employees: 76

Address: 26 Landsdowne Street, Cambridge, MA 02139

Phone: 617 651 8851

Last updated: 2024-12-31

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Therapeutic Candidates (INBRX-109, INBRX-106)

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.

Tags: biologic therapeutics, biopharmaceutical, cancer treatment, clinical-stage

Symbol: INBX

Recent Price: $15.14

Industry: Biotechnology

CEO: Mr. Mark Paul Lappe

Sector: Healthcare

Employees: 166

Address: 11025 North Torrey Pines Road, La Jolla, CA 92037

Phone: 858-795-4220

Last updated: 2024-12-31

Replimune Group, Inc.

Replimune Group, Inc. logo
Market Cap: Medium
Employees: Medium

RP1

Replimune Group, Inc. develops oncolytic immuno-gene therapies to treat cancer using its proprietary Immunotherapy platform. Its lead product, RP1, is in clinical trials for treating solid tumors.

Tags: RP1, biotechnology, cancer treatment, immunotherapy, oncolytic therapy

Symbol: REPL

Recent Price: $12.33

Industry: Biotechnology

CEO: Dr. Sushil Patel Ph.D.

Sector: Healthcare

Employees: 331

Address: 500 Unicorn Park Drive, Woburn, MA 01801

Phone: 781 222 9600

Last updated: 2024-12-31

Revelation Biosciences, Inc.

Revelation Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

REVTx-99b

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.

Tags: allergic rhinitis, biopharmaceutical, clinical trial, diagnostics, immune system therapeutics, kidney disease, nasal congestion, viral infections

Symbol: REVB

Recent Price: $0.39

Industry: Biotechnology

CEO: Mr. James M. Rolke

Sector: Healthcare

Employees: 9

Address: 4660 La Jolla Village Drive, San Diego, CA 92122

Phone: 650-800-3717

Last updated: 2024-12-31

Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

RP5063

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.

Tags: CNS diseases, RP1208, RP5063, biopharmaceutical, clinical-stage, therapeutics

Symbol: RVPH

Recent Price: $1.81

Industry: Biotechnology

CEO: Dr. Laxminarayan Bhat Ph.D.

Sector: Healthcare

Employees: 15

Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014

Phone: 408 501 8881

Last updated: 2024-12-31

Revvity, Inc.

Revvity, Inc. logo
Market Cap: Highest
Employees: Highest

Solutions for Diagnostics and Life Sciences

Revvity, Inc. offers a range of products, services, and solutions across diagnostics, life sciences, and applied services markets globally, with a focus on Discovery & Analytical Solutions and Diagnostics.

Tags: Analytical Solutions, Diagnostics, Imaging Technologies, Informatics, Instruments, Life Sciences, Reagents

Symbol: RVTY

Recent Price: $111.31

Industry: Medical - Diagnostics & Research

CEO: Dr. Prahlad R. Singh Ph.D.

Sector: Healthcare

Employees: 11000

Address: 940 Winter Street, Waltham, MA 02451

Phone: 781 663 6900

Last updated: 2024-12-31

Arvinas, Inc.

Arvinas, Inc. logo
Market Cap: High
Employees: Medium

Bavdegalutamide, ARV-471, ARV-766

Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.

Tags: PROTAC, biopharmaceutical, cancer therapy, clinical-stage, protein degrader

Symbol: ARVN

Recent Price: $19.00

Industry: Biotechnology

CEO: Dr. John G. Houston Ph.D.

Sector: Healthcare

Employees: 445

Address: 5 Science Park, New Haven, CT 06511

Phone: 203 535 1456

Leadership

  • John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
  • Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
  • Angela M. Cacace, Ph.D., Chief Scientific Officer
  • Jared Freedberg, J.D., General Counsel and Corporate Secretary
  • Paul McInulty, Senior Vice President, Regulatory Affairs
  • John Northcott, Chief Commercial Officer
  • Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
  • Andrew Saik, Chief Financial Officer
  • Lisa Sinclair, Senior Vice President, Corporate Operations
  • Ian Taylor, Ph.D., President, R&D
  • Randy Teel, Ph.D., Chief Business Officer
  • Steve Weiss, Senior Vice President, Chief Human Resources Officer

Last updated: 2024-12-31

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logo
Market Cap: Medium
Employees: Lowest

ANAVEX 2-73

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.

Tags: Alzheimer's, CNS diseases, Parkinson's, Rett syndrome, biopharmaceutical, clinical trials, neurodegenerative diseases

Symbol: AVXL

Recent Price: $11.04

Industry: Biotechnology

CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Sector: Healthcare

Employees: 40

Address: 51 West 52nd Street, New York, NY 10019

Phone: 844 689 3939

Last updated: 2024-12-31

BioVie Inc.

BioVie Inc. logo
Market Cap: Lowest
Employees: Lowest

BIV201, NE3107

Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.

Tags: Alzheimer's, Biotechnology, Clinical Trials, Drug Development, Liver Cirrhosis, Parkinson's, Pharmaceutical

Symbol: BIVI

Recent Price: $2.09

Industry: Biotechnology

CEO: Mr. Cuong Viet Do M.B.A.

Sector: Healthcare

Employees: 14

Address: 680 West Nye Lane, Carson City, NV 89703

Phone: 775 888 3162

Last updated: 2024-12-31

FibroGen, Inc.

FibroGen, Inc. logo
Market Cap: Lowest
Employees: Medium

Roxadustat, Pamrevlumab

Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.

Tags: anemia, antibody, biopharmaceutical, cancer, kidney disease, pulmonary fibrosis, therapeutics

Symbol: FGEN

Recent Price: $0.53

Industry: Biotechnology

CEO: Mr. Thane Wettig

Sector: Healthcare

Employees: 486

Address: 409 Illinois Street, San Francisco, CA 94158

Phone: 415 978 1200

Last updated: 2024-12-31

Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Roluperidone

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.

Tags: Parkinson's disease, biopharmaceutical, central nervous system, neurodegenerative disorders, schizophrenia

Symbol: NERV

Recent Price: $2.29

Industry: Biotechnology

CEO: Dr. Remy Luthringer Ph.D.

Sector: Healthcare

Employees: 9

Address: 1601 Trapelo Road, Waltham, MA 02451

Phone: 617 600 7373

Leadership

  • Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
  • Geoff Race, FCMA, MBA, President
  • Michael Davidson, M.D., Chief Medical Officer
  • Frederick Ahlholm, CPA, Chief Financial Officer
  • Joseph Reilly, Senior Vice President and Chief Operating Officer
  • Jay Saoud, PhD, Consultant
  • Hans Peter Hasler, Board Member
  • Jan van Heek, Board Member
  • David Kupfer, MD, Board Member
  • Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals

Last updated: 2024-12-31

Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. logo
Market Cap: Low
Employees: Low

Rani Pill

Rani Therapeutics Holdings, Inc. is a clinical stage biotherapeutics company focused on developing orally administered biologics with its Rani Pill platform, aimed at replacing subcutaneous or IV injections. The company has multiple products in various stages of development targeting conditions like neuroendocrine tumors, psoriatic arthritis, osteoporosis, growth hormone deficiency, hypoparathyroidism, and type 2 diabetes.

Tags: Rani Pill, biologics, biotherapeutics, clinical trials, healthcare, pharmaceuticals

Symbol: RANI

Recent Price: $1.48

Industry: Biotechnology

CEO: Mr. Talat Imran

Sector: Healthcare

Employees: 140

Address: 2051 Ringwood Avenue, San Jose, CA 95131

Phone: 408 457 3700

Leadership

  • Talat Imran, Chief Executive Officer
  • Mir Imran, Founder and Executive Chairman
  • Mir Hashim, Chief Scientific Officer
  • Svai Sanford, Chief Financial Officer
  • Eric Groen, General Counsel
  • Kate McKinley, Chief Business Officer
  • Jacques Van Dam, Vice President, Medical Affairs
  • Alireza Javadi, VP of Technical Operations
  • Betsy Gutierrez, Vice President, Quality Assurance
  • Bella Vazquez, Vice President, Human Resources
  • Kyle Horlen, VP of Nonclinical Development & Safety Assessment
  • Arvinder Dhalla, Vice President, Clinical Development
  • Andrew Farquharson, Managing Director, VHM and InCube Ventures
  • Maulik Nanavaty, CEO of Anumana
  • Jean-Luc Butel, Director at Takeda, Novo Holdings, and SG Innovate
  • Laureen DeBuono, Managing Partner, FLG Partners
  • Dennis Ausiello, Director of CATCH & Former Chief of Medicine, Mass General
  • Lisa Rometty, President, CVS Kidney Care

Last updated: 2024-12-31

RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

RPT193, FLX475

RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule therapies targeting oncology and inflammatory diseases. Its leading drug candidates include RPT193 for inflammation and FLX475 for oncology.

Tags: FLX475, RPT193, biopharmaceutical, clinical-stage, immunology, inflammatory diseases, oncology

Symbol: RAPT

Recent Price: $1.62

Industry: Biotechnology

CEO: Dr. Brian Russell Wong M.D., Ph.D.

Sector: Healthcare

Employees: 122

Address: 561 Eccles Avenue, South San Francisco, CA 94080

Phone: 650 489 9000

Last updated: 2024-12-31

Renovaro Biosciences Inc.

Renovaro Biosciences Inc. logo
Market Cap: Lowest
Employees: Lowest

RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21

Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.

Tags: HBV treatment, HIV treatment, biotechnology, cancer treatment, pharmaceutical research, strategic partnerships

Symbol: RENB

Recent Price: $0.87

Industry: Biotechnology

CEO: Mr. David H. Weinstein

Sector: Healthcare

Employees: 25

Address: 2080 Century Park East, Los Angeles, CA 90067

Phone: 305 918 1980

Last updated: 2024-12-31

RenovoRx, Inc.

RenovoRx, Inc. logo
Market Cap: Lowest
Employees: Lowest

Renovo Gem

Renovo Rx, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapies for the treatment of solid tumors, with its lead product candidate, Renovo Gem, in Phase III clinical trials for locally advanced pancreatic cancer.

Tags: Renovo Gem, biopharmaceutical, clinical trials, pancreatic cancer, solid tumors

Symbol: RNXT

Recent Price: $1.39

Industry: Biotechnology

CEO: Mr. Shaun R. Bagai

Sector: Healthcare

Employees: 8

Address: 4546 El Camino Real, Los Altos, CA 94022

Phone: 650 284 4433

Leadership

  • Shaun R. Bagai, Director and Chief Executive Officer
  • Ramtin Agah, MD, Chairman, Chief Medical Officer, and Founder
  • Leesa Gentry, Chief Clinical Officer
  • Ronald B. Kocak, CPA, VP Controller and Principal Accounting Officer
  • Ryan Witt, Senior Vice President, Head of Corporate Strategy and Partnerships
  • Imtiaz Qureshi, MD, Director of Imaging
  • Angela Macfarlane, CEO of Perceive Biotherapeutics, Inc.
  • Laurence J. Marton, MD, Director
  • Una S. Ryan, PhD, OBE, Director
  • Robert J. Spiegel, Director

Last updated: 2024-12-31

Revolution Medicines, Inc.

Revolution Medicines, Inc. logo
Market Cap: Highest
Employees: Medium

RMC-4630

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing therapies targeting frontier targets in RAS-addicted cancers.

Tags: RAS-addicted cancers, cancer therapy, clinical trials, oncology, precision medicine

Symbol: RVMD

Recent Price: $43.17

Industry: Biotechnology

CEO: Dr. Mark A. Goldsmith Ph.D.

Sector: Healthcare

Employees: 378

Address: 700 Saginaw Drive, Redwood City, CA 94063

Phone: 650 481 6801

Last updated: 2024-12-31

Revance Therapeutics, Inc.

Revance Therapeutics, Inc. logo
Market Cap: Medium
Employees: Medium

Daxibotulinumtoxin A

Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.

Tags: aesthetic, biotechnology, clinical trials, neuromodulators, therapeutic

Symbol: RVNC

Recent Price: $3.06

Industry: Biotechnology

CEO: Mr. Mark J. Foley

Sector: Healthcare

Employees: 597

Address: 1222 Demonbreun Street, Nashville, TN 37203

Phone: 615 724 7755

Leadership

  • Mark J. Foley, Chief Executive Officer
  • Tobin Schilke, Chief Financial Officer
  • Erica Jordan, Chief Commercial Officer
  • Dwight O. Moxie, Chief Legal Officer and General Counsel
  • Amie Krause, Chief People Officer
  • David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
  • Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
  • Chris Nolet, Chair, Audit Committee
  • Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
  • Vlad Coric,
  • Julian S. Gangolli,
  • Carey O’Connor Kolaja,
  • Olivia C. Ware,

Last updated: 2024-12-31

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

REC-994

Recursion Pharmaceuticals is a clinical-stage biotechnology company focusing on decoding biology to industrialize drug discovery, integrating technological innovations across multiple disciplines.

Tags: automation, biology, biotechnology, chemistry, clinical-stage, data science, drug discovery, engineering

Symbol: RXRX

Recent Price: $6.77

Industry: Biotechnology

CEO: Dr. Christopher C. Gibson Ph.D.

Sector: Healthcare

Employees: 500

Address: 41 South Rio Grande Street, Salt Lake City, UT 84101

Phone: 385 269 0203

Last updated: 2024-12-31

Theriva Biologics, Inc.

Theriva Biologics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SYN-004, SYN-020, VCN-01

Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.

Tags: biologics, biopharmaceutical, clinical-stage, disease treatment, microbiome, therapeutics

Symbol: TOVX

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Steven A. Shallcross CPA

Sector: Healthcare

Employees: 22

Address: 9605 Medical Center Drive, Rockville, MD 20850

Phone: 301 417 4364

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08